1. Home
  2. CIEN vs RMD Comparison

CIEN vs RMD Comparison

Compare CIEN & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ciena Corporation

CIEN

Ciena Corporation

HOLD

Current Price

$237.03

Market Cap

32.4B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$243.40

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIEN
RMD
Founded
1992
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4B
36.4B
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
CIEN
RMD
Price
$237.03
$243.40
Analyst Decision
Strong Buy
Buy
Analyst Count
15
13
Target Price
$219.29
$289.09
AVG Volume (30 Days)
3.0M
924.4K
Earning Date
12-11-2025
01-29-2026
Dividend Yield
N/A
0.98%
EPS Growth
46.55
29.59
EPS
0.85
9.77
Revenue
$4,769,507,000.00
$5,257,400,000.00
Revenue This Year
$27.20
$9.85
Revenue Next Year
$15.92
$7.36
P/E Ratio
$284.33
$25.05
Revenue Growth
18.79
9.36
52 Week Low
$49.21
$199.92
52 Week High
$248.00
$293.81

Technical Indicators

Market Signals
Indicator
CIEN
RMD
Relative Strength Index (RSI) 62.35 40.87
Support Level $201.70 $241.66
Resistance Level $242.51 $245.99
Average True Range (ATR) 11.63 4.62
MACD 1.58 -0.30
Stochastic Oscillator 75.04 9.38

Price Performance

Historical Comparison
CIEN
RMD

About CIEN Ciena Corporation

Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: